{"url_path":"/sec/xtnt/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1453593/0001493152-26-036979-index.html","accession_number":"0001493152-26-036979","cik":"0001453593","ticker":"XTNT","issuer_name":"Xtant Medical Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1453593/0001493152-26-036979-index.html","primary_entity_key":"0001453593","primary_entity_name":"Xtant Medical Holdings, Inc."},"word_count":96,"has_tables":true,"body_markdown":"** **\n\n**Item 9.01**\n**Financial Statements and\nExhibits.**\n\n \n\n*(d)\nExhibits.*\n\n \n\n**Exhibit\nNo.**\n\n \n\n**Description**\n\n99.1\n\n \n\n \n\n[Press Release of Xtant Medical Holdings, Inc. dated August 11, 2026 entitled “Xtant Medical Reports Second Quarter 2026 Financial Results” (furnished herewith)](ex99-1.htm)\n\n104\n\n \n\nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURE**\n\n** **\n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n**XTANT\nMEDICAL HOLDINGS, INC.**\n\n \n \n\n \nBy:\n\n*/s/\nScott C. Neils*\n\n \n \nScott\nC. Neils\n\n \n* *\n*Chief\nFinancial Officer*\n\n* *\n\nDate:\nAugust 11, 2026"}